News |
Dr Clive Black, Vice Chairman speaks at Northern Ireland Food and Drink Conference
The first of its kind, the NI Food and Drink Conference saw 150 delegates from across industry and government come […]
News |
The first of its kind, the NI Food and Drink Conference saw 150 delegates from across industry and government come […]
News |
Shore Capital is delighted to have acted as Financial Adviser, Broker and Bookrunner on an oversubscribed £12 million Placing and […]
News |
We are delighted to have been appointed as Joint Broker to Accrol Group Holdings plc (AIM: ACRL), adding to Shore […]
News |
We are delighted to have been appointed as Nomad and Sole Broker to musicMagpie plc (AIM:MMAG). Stockport based musicMagpie plc […]
News |
Shore Capital is delighted to have acted as Joint Broker and Joint Bookrunner for Destiny Pharma plc (AIM: DEST) on […]
News |
Shore Capital is delighted to have been appointed as Nominated Adviser and Joint Broker to Portmeirion Group plc (AIM: PMP). […]
News |
Shore Capital is delighted to have acted as Joint Bookrunner for OnTheMarket plc (AIM: OTMP) on a secondary placing of […]
News |
Shore Capital is delighted to have acted as Joint Bookrunner for Petro Matad Limited (AIM: MATD) on a US$6m placing […]
News |
Shore Capital is delighted to have acted as Nominated Adviser and UK Joint Bookrunner for Touchstone Exploration (AIM:TXP) on an […]
News |
Shore Capital is delighted to have acted as Nomad, Broker and Sole Bookrunner for Helios Underwriting plc (AIM: HUW) on […]
News |
Shore Capital is delighted to be appointed as Joint Corporate Broker to Destiny Pharma plc (AIM: DEST). Destiny Pharma is […]
News |
One of the features of Italian politics is that technocrats are periodically invited to form a government, particularly after periods […]
News |
Shore Capital is delighted to have acted as Joint Corporate Broker and Joint Bookrunner for ThomasLloyd Energy Impact Trust plc […]
News |
Shore Capital is delighted to have acted as Joint Bookrunner for Eagle Eye Solutions Group (AIM: EYE) on a £7m […]
News |
Shore Capital is delighted to be appointed as joint Corporate Broker to SSP Group plc (LON: SSPG). With a market capitalisation […]
News |
Oxford BioDynamics (AIM:OBD) a biotechnology company developing targeted clinical diagnostic tests for immune health based on the EpiSwitch® 3D genomics […]
News |
H&T Group (AIM:HAT) has successfully raised £16.9m via an oversubscribed placing and retail offer, with Shore Capital acting as Sole […]
News |
Shore Capital is pleased to announce that it has been appointed as Nomad and Sole Broker to Warpaint London (AIM:WZL); […]